Invesco FTSE Emerging Markets High Dividend Low Volatility vs UBS Lux Equity Fund Biotech USD

Invesco FTSE Emerging Markets High Dividend Low Volatility vs UBS Lux Equity Fund Biotech USD

1. Invesco FTSE Emerging Markets High Dividend Low Volatility

  • Security

    Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETF Dist

  • Fee

    0.49%

  • ISIN

    IE00BYYXBF44

  • Holdings

    6

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 7 holdings in Invesco FTSE Emerging Markets High Dividend Low Volatility, where the largest holding is Vedanta (3.17), followed by ČEZ (2.44) and CEMIG (1.91). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Invesco FTSE Emerging Markets High Dividend Low Volatility and UBS Lux Equity Fund Biotech USD.

Invesco FTSE Emerging Markets High Dividend Low Volatility UBS Lux Equity Fund Biotech USD
1. Vedanta Ltd
India
3.17 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. ČEZ AS
Czech Republic
2.44 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Companhia Energética de Minas Gerais ADR
Brazil
1.91 %
3. Moderna Inc
9.21 %
4. China Shenhua Energy Co Ltd Class H
China
1.9 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. China Petroleum & Chemical Corp Class H
China
1.73 %
5. AbbVie Inc
USA
5.52 %
6. Bancolombia SA ADR
Colombia
1.52 %
6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
4.32 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.